e.016 meets Dr. Mandell - a scientist, entrepreneur, and leading expert in synthetic biology, protein engineering, artificial intelligence, and biological and medical informatics. Together with Dr. George Church, he leveraged Genomically Recoded Organisms (GROs) to produce the first proteins with stability and function dependent on non-standard amino acids. Last November Grobio closed a $25 million Series A financing led by  Leaps by Bayer and Redmile, a total investment to date of $31.2 million, to help fund the company’s scale-up of bioprocess manufacturing, preclinical validation studies and IND enabling studies.

Dr. Mandell completed his research fellowship in genetics at Harvard Medical School where he was Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. He received his PhD from the University of California, San Francisco, his MSc at University of Edinburgh, and his undergraduate degree in Symbolic Systems from Stanford University.